Sapient Capital’s Quest Diagnostics DGX Stock Holding History

Sapient Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.6M	Buy	+32,609	New	+$7.54M	0.1%	97

Other funds holding DGX

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return

Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sapient Capital's DGX Position: Q3 2026 in Review

Sapient Capital opened a new position in Quest Diagnostics (DGX) in Q3 2026: 32,609 shares worth $7.6M. The stake represents 0.1% of the portfolio and ranks #97 among its holdings.

48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Sapient Capital held 32,609 shares of Quest Diagnostics worth $7.6M as of Q3 2026.
Quest Diagnostics was a new Sapient Capital position in Q3 2026.
Quest Diagnostics made up 0.1% of Sapient Capital's portfolio in Q3 2026, its #97 holding.
48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.